UNLIMITED

STAT

Opinion: Community engagement is key to clinical trial recruitment and diversity

Two birds, one stone: improving diversity in clinical trials will simultaneously improve participation.
Kenneth Parker Ulrich (left), a research technician at the University of Pittsburgh Medical Center, prepares to collect a blood sample from Erricka Hager, a participant in All of Us.

Clinical trials in the United States have been plagued for years by two well-known problems: They don’t recruit enough people and they fail to reflect the diversity of our nation.

The good news is that solving the diversity problem can resolve both issues. Two birds, one stone.

Researchers whose job it is to fill clinical trials with participants have begun teaming up with tech companies to find modern solutions to this long-standing problem. This approach, however, is just a temporary patch to a problem that requires a longer, more sustained remedy.

First, the facts: 25% of cancer trials as many participants as they need, and 18% of trials close with fewer than half of do not reach recruitment targets within their specified time periods.

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min readAmerican Government
Opinion: STAT+: Pharmacy Benefits Managers Should Be Worried
Former FTC policy director David Balto says PBMs should be very worried about the new Trump administration and pending congressional action.
STAT1 min read
STAT+: Ionis Blazed Trails In Genetic Medicine. On The Cusp Of A Major Approval, Can It Also Be A Commercial Success?
Ionis is expecting a FDA decision by Dec. 19 on approval of a drug designed to improve the body’s ability to break down fats
STAT1 min read
Opinion: In A Threat To Patient Trust, Texas Hospitals Must Ask ‘Are You A U.S. Citizen?’
Akshara Ramasamy will soon begin medical school in Texas — but the state’s new requirement to ask hospital patients about immigration status worries her.

Related Books & Audiobooks